MyAverix Finance
US · Healthcare
MERCK Kommanditgesellschaft auf Aktien (MKGAF)
Drug Manufacturers - Specialty & Generic
MERCK Kommanditgesellschaft auf Aktien (MKGAF) is listed on US in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-24, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for MKGAF
MERCK Kommanditgesellschaft auf Aktien (MKGAF) — FAQ
What is MKGAF's P/E ratio?
The price-to-earnings (P/E) ratio for MERCK Kommanditgesellschaft auf Aktien (MKGAF) is 18.00 (data as of 2026-03-24).
Does MERCK Kommanditgesellschaft auf Aktien pay a dividend?
Dividend yield is not available in the current snapshot for MERCK Kommanditgesellschaft auf Aktien (MKGAF). Check the MyAverix Finance app for the latest dividend data.
What sector is MERCK Kommanditgesellschaft auf Aktien in?
MERCK Kommanditgesellschaft auf Aktien (MKGAF) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is MKGAF listed on?
MKGAF is listed on US.
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.